45
29. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, et
al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular
carcinomas and hepatoblastomas. Oncogene. 2002 Jul 18;21(31):4863-71.
30. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-
Preiser C, et al. beta-Catenin mutation is a frequent cause of Wnt pathway
activation in gastric cancer. Cancer Res. 2002 Jun 15;62(12):3503-6.
31. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, et al. Frequent
somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.
Cancer Res. 1999 Sep 1;59(17):4257-60.
32. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K,
et al. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Tumour Biol. 2001 Mar-Apr;22(2):123-30.
33. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T. Accumulation
of beta-catenin protein and mutations in exon 3 of beta-catenin gene in
gastrointestinal carcinoid tumor. Cancer Res. 2001 Sep 15;61(18):6656-9.
34. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M,
et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct
from pancreatic ductal adenocarcinomas and almost always harbor beta-
catenin mutations. Am J Pathol. 2002 Apr;160(4):1361-9.
35. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, et al.
Beta-catenin mutations are specific for colorectal carcinomas with
microsatellite instability but occur in endometrial carcinomas irrespective of
mutator pathway. Cancer Res. 1999 Jul 15;59(14):3346-51.
36. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R,
Garcia-Rostan G, et al. Abnormalities of the APC/beta-catenin pathway in
endometrial cancer. Oncogene. 2002 Nov 14;21(52):7981-90.
37. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas
A. beta-catenin expression pattern in stage I and II ovarian carcinomas :
relationship with beta-catenin gene mutations, clinicopathological features,
and clinical outcome. Am J Pathol. 1999 Aug;155(2):527-36.
38. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-
catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res.
2001 Nov 15;61(22):8247-55.
39. Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in human
prostate cancer. Cancer Res. 1998 Jun 15;58(12):2520-3.
40. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML,
Rimm DL. Frequent mutation and nuclear localization of beta-catenin in
anaplastic thyroid carcinoma. Cancer Res. 1999 Apr 15;59(8):1811-5.
41. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL,
Tallini G. Beta-catenin dysregulation in thyroid neoplasms: down-regulation,
aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for
aggressive tumor phenotypes and poor prognosis. Am J Pathol. 2001
Mar;158(3):987-96.
42. Maiti S, Alam R, Amos CI, Huff V. Frequent association of beta-
catenin and WT1 mutations in Wilms tumors. Cancer Res. 2000 Nov
15;60(22):6288-92.